Phibro Animal Health (PAHC) Non Operating Income (2014 - 2026)
Phibro Animal Health's (PAHC) quarterly Non Operating Income came in at -$10.4 million in Q1 2026, down 11.5% year-on-year from -$11.8 million in Q1 2025, and up 11.27% quarter-over-quarter from -$11.8 million in Q4 2025.
Phibro Animal Health (PAHC) Non Operating Income (2014 - 2026) Analysis & Trends
Phibro Animal Health's Non Operating Income history runs 7 years deep, the most recent figure standing at -$10.4 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 11.5% year-over-year to -$10.4 million in Q1 2026; TTM through Mar 2026 was -$42.9 million, a 39.46% decrease from a year earlier, with the FY2025 full-year figure at -$34.6 million, down 86.67% from the prior year.
- Non Operating Income advanced to -$10.4 million in Q1 2026 per PAHC's latest filing, from -$11.8 million in the prior quarter.
- Across five years, Non Operating Income topped out at -$4.6 million in Q3 2023 and bottomed at -$12.1 million in Q3 2025.
- The 4-year median for Non Operating Income is -$8.6 million (2025), against an average of -$7.9 million.
- Across the five-year window, Non Operating Income slumped 104.48% in 2025 and fell 11.5% in 2026, its largest moves.
- Year by year, Non Operating Income stood at -$4.7 million in 2023, then plunged by 93.09% to -$9.0 million in 2024, then tumbled by 30.68% to -$11.8 million in 2025, then grew by 11.27% to -$10.4 million in 2026.
- Per Business Quant, the three latest PAHC Non Operating Income figures stand at -$10.4 million (Q1 2026), -$11.8 million (Q4 2025), and -$12.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | -10.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.43 Mn |
| Dec 31, 2025 | -11.76 Mn |
| Sep 30, 2025 | -12.06 Mn |
| Jun 30, 2025 | -8.61 Mn |
| Mar 31, 2025 | -9.36 Mn |
| Dec 31, 2024 | -9.00 Mn |
| Sep 30, 2024 | -7.64 Mn |
| Jun 30, 2024 | -4.74 Mn |
| Mar 31, 2024 | -4.58 Mn |
| Dec 31, 2023 | -4.66 Mn |
| Sep 30, 2023 | -4.56 Mn |
| Mar 31, 2016 | -4.27 Mn |
| Dec 31, 2015 | -3.97 Mn |
| Sep 30, 2015 | -3.82 Mn |
| Mar 31, 2015 | -3.60 Mn |
| Dec 31, 2014 | -3.52 Mn |
| Sep 30, 2014 | -3.49 Mn |